ArticleFrontiers in oncology2022

Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients.

Stefano Mariani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.